Lars Ekman Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Lars Ekman.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Lars Ekman. Lars Ekman is in AMARIN CORP PLC\UK ($AMRN) and Director in AMARIN CORP PLC\UK ($AMRN) and Director in INTERMUNE INC ($ITMN) and in Ultragenyx Pharmaceutical Inc. ($RARE) and Director in Ultragenyx Pharmaceutical Inc. ($RARE) and Director in Prothena Corp plc ($PRTA) and Director in SOPHIRIS BIO INC. ($SPHS) and Director in Spark Therapeutics, Inc. ($ONCE).
Latest Insider Trading Transactions of Lars Ekman
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AMRN, ITMN, PRTA, SPHS, ONCE, RARE
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 28 2021 | RARE | Ultragenyx Pharmac ... | Ekman Lars | Director | Option Exercise | A | 93.20 | 4,125 | 384,450 | 4,125 | |
Jun 28 2021 | RARE | Ultragenyx Pharmac ... | Ekman Lars | Director | Grant | A | 0.00 | 2,145 | 0 | 14,445 | 12.3 K to 14.4 K (+17.44 %) |
Jun 16 2021 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Option Exercise | A | 0.00 | 38,000 | 0 | 38,000 | ||
Jun 16 2021 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Option Exercise | A | 5.00 | 48,506 | 242,530 | 48,506 | ||
Jul 15 2020 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Option Exercise | A | 0.00 | 28,702 | 0 | 28,702 | ||
Jul 15 2020 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Option Exercise | A | 6.62 | 36,739 | 243,212 | 36,739 | ||
Jul 15 2020 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Option Exercise | A | 0.00 | 28,702 | 0 | 28,702 | ||
Jul 15 2020 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Option Exercise | A | 6.62 | 36,739 | 243,212 | 36,739 | ||
Jun 30 2020 | RARE | Ultragenyx Pharmac ... | Ekman Lars | Director | Option Exercise | A | 76.58 | 4,250 | 325,465 | 4,250 | |
Jun 30 2020 | RARE | Ultragenyx Pharmac ... | Ekman Lars | Director | Grant | A | 0.00 | 2,550 | 0 | 12,300 | 9.8 K to 12.3 K (+26.15 %) |
May 22 2020 | PRTA | Prothena Corp plc | Ekman Lars | Director | Option Exercise | A | 11.33 | 17,500 | 198,275 | 17,500 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Ekman Lars | Director | Option Exercise | D | 3.45 | 37,203 | 128,350 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Ekman Lars | Director | Option Exercise | D | 56.22 | 6,000 | 337,320 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Ekman Lars | Director | Option Exercise | D | 50.93 | 4,000 | 203,720 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Ekman Lars | Director | Option Exercise | D | 81.53 | 4,000 | 326,120 | 0 | |
Dec 17 2019 | ONCE | Spark Therapeutics ... | Ekman Lars | Director | Sell | U | 114.50 | 3,000 | 343,500 | 0 | 3 K to 0 (-100.00 %) |
Nov 13 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Option Exercise | M | 14.40 | 38,600 | 555,840 | 0 | |
Nov 13 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Option Exercise | M | 14.40 | 38,600 | 555,840 | 0 | |
Nov 13 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Sell | S | 19.35 | 38,600 | 746,759 | 0 | 38.6 K to 0 (-100.00 %) |
Nov 13 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Sell | S | 19.35 | 38,600 | 746,759 | 0 | 38.6 K to 0 (-100.00 %) |
Nov 13 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Buy | M | 14.40 | 38,600 | 555,840 | 38,600 | 0 to 38.6 K |
Nov 13 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Buy | M | 14.40 | 38,600 | 555,840 | 38,600 | 0 to 38.6 K |
Nov 07 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Option Exercise | M | 14.40 | 6,400 | 92,160 | 38,600 | |
Nov 07 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Sell | S | 18.00 | 6,400 | 115,230 | 0 | 6.4 K to 0 (-100.00 %) |
Nov 07 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Buy | M | 14.40 | 6,400 | 92,160 | 6,400 | 0 to 6.4 K |
Sep 05 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Option Exercise | M | 3.21 | 51,671 | 165,864 | 0 | |
Sep 05 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Option Exercise | M | 3.06 | 25,845 | 79,086 | 0 | |
Sep 05 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Option Exercise | M | 5.58 | 13,500 | 75,330 | 0 | |
Sep 05 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Sell | S | 15.01 | 91,016 | 1,365,722 | 0 | 91 K to 0 (-100.00 %) |
Sep 05 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Buy | M | 3.21 | 51,671 | 165,864 | 91,016 | 39.3 K to 91 K (+131.33 %) |
Sep 05 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Buy | M | 3.06 | 25,845 | 79,086 | 39,345 | 13.5 K to 39.3 K (+191.44 %) |
Sep 05 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Buy | M | 5.58 | 13,500 | 75,330 | 13,500 | 0 to 13.5 K |
Jun 28 2019 | SPHS | SOPHIRIS BIO INC. | Ekman Lars | Director | Option Exercise | A | 0.78 | 20,000 | 15,564 | 20,000 | |
Jun 13 2019 | RARE | Ultragenyx Pharmac ... | Ekman Lars | Director | Option Exercise | A | 58.74 | 5,000 | 293,700 | 5,000 | |
Jun 13 2019 | RARE | Ultragenyx Pharmac ... | Ekman Lars | Director | Grant | A | 0.00 | 3,000 | 0 | 9,750 | 6.8 K to 9.8 K (+44.44 %) |
Jun 03 2019 | ONCE | Spark Therapeutics ... | Ekman Lars | Director | Option Exercise | M | 0.00 | 1,500 | 0 | 0 | |
Jun 03 2019 | ONCE | Spark Therapeutics ... | Ekman Lars | Director | Buy | M | 0.00 | 1,500 | 0 | 3,000 | 1.5 K to 3 K (+100.00 %) |
May 24 2019 | PRTA | Prothena Corp plc | Ekman Lars | Director | Option Exercise | A | 9.23 | 17,500 | 161,525 | 17,500 | |
May 21 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Option Exercise | A | 0.00 | 8,023 | 0 | 8,023 | |
May 21 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Option Exercise | A | 16.83 | 10,431 | 175,554 | 10,431 | |
Mar 06 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Option Exercise | M | 2.50 | 28,287 | 70,718 | 0 | |
Mar 06 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Option Exercise | M | 2.50 | 17,358 | 43,395 | 0 | |
Mar 06 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Option Exercise | M | 2.19 | 35,258 | 77,215 | 0 | |
Mar 06 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Option Exercise | M | 1.87 | 28,500 | 53,295 | 0 | |
Mar 06 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Option Exercise | M | 1.87 | 6,390 | 11,949 | 0 | |
Mar 06 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Option Exercise | M | 1.03 | 19,584 | 20,172 | 0 | |
Mar 06 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Sell | S | 21.71 | 36,700 | 796,830 | 0 | 36.7 K to 0 (-100.00 %) |
Mar 06 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Sell | S | 21.16 | 98,677 | 2,088,074 | 36,700 | 135.4 K to 36.7 K (-72.89 %) |
Mar 06 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Buy | M | 2.50 | 28,287 | 70,718 | 135,377 | 107.1 K to 135.4 K (+26.41 %) |
Mar 06 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Buy | M | 2.50 | 17,358 | 43,395 | 107,090 | 89.7 K to 107.1 K (+19.34 %) |
Mar 06 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Buy | M | 2.19 | 35,258 | 77,215 | 89,732 | 54.5 K to 89.7 K (+64.72 %) |
Mar 06 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Buy | M | 1.87 | 28,500 | 53,295 | 54,474 | 26 K to 54.5 K (+109.73 %) |
Mar 06 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Buy | M | 1.87 | 6,390 | 11,949 | 25,974 | 19.6 K to 26 K (+32.63 %) |
Mar 06 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Buy | M | 1.03 | 19,584 | 20,172 | 19,584 | 0 to 19.6 K |
Jan 11 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Option Exercise | M | 1.03 | 100,416 | 103,428 | 19,584 | |
Jan 11 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Sell | S | 18.62 | 7,496 | 139,603 | 0 | 7.5 K to 0 (-100.00 %) |
Jan 11 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Sell | S | 18.16 | 55,762 | 1,012,671 | 7,496 | 63.3 K to 7.5 K (-88.15 %) |
Jan 11 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Sell | S | 17.29 | 48,711 | 842,140 | 63,258 | 112 K to 63.3 K (-43.50 %) |
Jan 11 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Sell | S | 15.96 | 7,247 | 115,678 | 111,969 | 119.2 K to 112 K (-6.08 %) |
Jan 11 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Sell | S | 14.92 | 21,200 | 316,397 | 119,216 | 140.4 K to 119.2 K (-15.10 %) |
Jan 11 2019 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Buy | M | 1.03 | 100,416 | 103,428 | 140,416 | 40 K to 140.4 K (+251.04 %) |
Oct 02 2018 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Option Exercise | A | 0.00 | 34,269 | 0 | 34,269 | |
Oct 02 2018 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Option Exercise | A | 3.21 | 51,671 | 165,864 | 51,671 | |
Jun 28 2018 | SPHS | SOPHIRIS BIO INC. | Ekman Lars | Director | Option Exercise | A | 2.91 | 20,000 | 58,200 | 20,000 | |
Jun 20 2018 | RARE | Ultragenyx Pharmac ... | Ekman Lars | Director | Option Exercise | A | 80.69 | 5,000 | 403,450 | 5,000 | |
Jun 20 2018 | RARE | Ultragenyx Pharmac ... | Ekman Lars | Director | Grant | A | 0.00 | 3,000 | 0 | 6,750 | 3.8 K to 6.8 K (+80.00 %) |
May 31 2018 | ONCE | Spark Therapeutics ... | Ekman Lars | Director | Option Exercise | M | 0.00 | 1,500 | 0 | 0 | |
May 31 2018 | ONCE | Spark Therapeutics ... | Ekman Lars | Director | Option Exercise | A | 0.00 | 1,500 | 0 | 1,500 | |
May 31 2018 | ONCE | Spark Therapeutics ... | Ekman Lars | Director | Option Exercise | A | 81.53 | 4,000 | 326,120 | 4,000 | |
May 31 2018 | ONCE | Spark Therapeutics ... | Ekman Lars | Director | Buy | M | 0.00 | 1,500 | 0 | 1,500 | 0 to 1.5 K |
May 31 2018 | ONCE | Spark Therapeutics ... | Ekman Lars | Director | Option Exercise | M | 0.00 | 1,500 | 0 | 0 | |
May 31 2018 | ONCE | Spark Therapeutics ... | Ekman Lars | Director | Option Exercise | A | 0.00 | 1,500 | 0 | 1,500 | |
May 31 2018 | ONCE | Spark Therapeutics ... | Ekman Lars | Director | Option Exercise | A | 81.53 | 4,000 | 326,120 | 4,000 | |
May 31 2018 | ONCE | Spark Therapeutics ... | Ekman Lars | Director | Buy | M | 0.00 | 1,500 | 0 | 1,500 | 0 to 1.5 K |
May 18 2018 | PRTA | Prothena Corp plc | Ekman Lars | Director | Option Exercise | A | 16.43 | 12,000 | 197,160 | 12,000 | |
Jun 22 2017 | RARE | Ultragenyx Pharmac ... | Ekman Lars | Director | Option Exercise | A | 65.66 | 3,750 | 246,225 | 3,750 | |
Jun 22 2017 | RARE | Ultragenyx Pharmac ... | Ekman Lars | Director | Grant | A | 0.00 | 1,875 | 0 | 3,750 | 1.9 K to 3.8 K (+100.00 %) |
Jun 02 2017 | ONCE | Spark Therapeutics ... | Ekman Lars | Director | Option Exercise | A | 0.00 | 1,500 | 0 | 1,500 | |
Jun 02 2017 | ONCE | Spark Therapeutics ... | Ekman Lars | Director | Option Exercise | A | 50.93 | 4,000 | 203,720 | 4,000 | |
Jun 01 2017 | SPHS | SOPHIRIS BIO INC. | Ekman Lars | Director | Option Exercise | A | 2.44 | 20,000 | 48,800 | 20,000 | |
May 19 2017 | PRTA | Prothena Corp plc | Ekman Lars | Director | Option Exercise | A | 56.23 | 12,000 | 674,760 | 12,000 | |
May 17 2017 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Option Exercise | A | 0.00 | 17,974 | 0 | 17,974 | |
May 17 2017 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Option Exercise | A | 3.06 | 25,845 | 79,086 | 25,845 | |
Jul 13 2016 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Option Exercise | A | 0.00 | 25,115 | 0 | 25,115 | |
Jul 13 2016 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Option Exercise | A | 2.19 | 35,258 | 77,215 | 35,258 | |
Jun 14 2016 | RARE | Ultragenyx Pharmac ... | Ekman Lars | Option Exercise | A | 65.85 | 3,750 | 246,938 | 3,750 | ||
Jun 14 2016 | RARE | Ultragenyx Pharmac ... | Ekman Lars | Grant | A | 0.00 | 1,875 | 0 | 1,875 | 0 to 1.9 K | |
Jun 03 2016 | ONCE | Spark Therapeutics ... | Ekman Lars | Director | Option Exercise | A | 56.22 | 6,000 | 337,320 | 6,000 | |
May 31 2016 | SPHS | SOPHIRIS BIO INC. | Ekman Lars | Director | Option Exercise | A | 0.99 | 8,250 | 8,168 | 8,250 | |
May 24 2016 | PRTA | Prothena Corp plc | Ekman Lars | Director | Option Exercise | A | 42.50 | 15,000 | 637,500 | 15,000 | |
Mar 21 2016 | RARE | Ultragenyx Pharmac ... | Ekman Lars | Option Exercise | A | 54.28 | 15,000 | 814,200 | 15,000 | ||
Nov 25 2015 | PRTA | Prothena Corp plc | Ekman Lars | Director | Option Exercise | M | 6.41 | 30,000 | 192,300 | 95,000 | |
Nov 25 2015 | PRTA | Prothena Corp plc | Ekman Lars | Director | Sell | S | 74.43 | 1,910 | 142,171 | 243 | 2.2 K to 243 (-88.71 %) |
Nov 25 2015 | PRTA | Prothena Corp plc | Ekman Lars | Director | Sell | S | 73.73 | 11,502 | 847,999 | 2,153 | 13.7 K to 2.2 K (-84.23 %) |
Nov 25 2015 | PRTA | Prothena Corp plc | Ekman Lars | Director | Sell | S | 72.96 | 16,588 | 1,210,264 | 13,655 | 30.2 K to 13.7 K (-54.85 %) |
Nov 25 2015 | PRTA | Prothena Corp plc | Ekman Lars | Director | Buy | M | 6.41 | 30,000 | 192,300 | 30,243 | 243 to 30.2 K (+12,345.68 %) |
Jul 08 2015 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Option Exercise | A | 0.00 | 22,000 | 0 | 22,000 | |
Jul 08 2015 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Option Exercise | A | 0.00 | 40,500 | 0 | 40,500 | |
Jul 08 2015 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Option Exercise | A | 2.50 | 28,287 | 70,718 | 28,287 | |
Jul 08 2015 | AMRN | AMARIN CORP PLC\UK | Ekman Lars | Director | Option Exercise | A | 2.50 | 17,358 | 43,395 | 17,358 | |
May 28 2015 | SPHS | SOPHIRIS BIO INC. | Ekman Lars | Director | Option Exercise | A | 1.08 | 8,250 | 8,910 | 8,250 | |
May 26 2015 | PRTA | Prothena Corp plc | Ekman Lars | Director | Option Exercise | A | 34.04 | 15,000 | 510,600 | 15,000 | |
May 12 2011 | ITMN | INTERMUNE INC | Ekman Lars | Director | Option Exercise | A | 39.46 | 12,000 | 473,520 | 12,000 | |
Sep 27 2010 | ITMN | INTERMUNE INC | Ekman Lars | Director | Option Exercise | A | 12.96 | 15,000 | 194,415 | 15,000 | |
May 10 2010 | ITMN | INTERMUNE INC | Ekman Lars | Director | Option Exercise | A | 10.37 | 12,000 | 124,440 | 93,003 | |
Jun 24 2009 | ITMN | INTERMUNE INC | Ekman Lars | Director | Option Exercise | A | 11.33 | 12,000 | 135,960 | 81,003 | |
May 15 2008 | ITMN | INTERMUNE INC | Ekman Lars | Director | Option Exercise | A | 15.34 | 12,000 | 184,080 | 69,003 | |
May 17 2007 | ITMN | INTERMUNE INC | Ekman Lars | Director | Option Exercise | A | 25.55 | 12,000 | 306,600 | 57,003 | |
Sep 20 2006 | ITMN | INTERMUNE INC | Ekman Lars | Director | Option Exercise | A | 17.05 | 15,003 | 255,801 | 15,003 | |
Sep 20 2006 | ITMN | INTERMUNE INC | Ekman Lars | Director | Option Exercise | A | 17.05 | 30,000 | 511,500 | 30,000 |
Page: 1